Development of a Multiplexed LC-MS/MS Assay for the Quantitation of Podocyte Injury Biomarkers Nephrin, Podocalyxin, and Podocin in Human Urine., PMID:39651829
Immunogenicity, Immunological Memory and Monitoring of Disease Activity Following an Anamnestic Immunization With the 13-Valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome., PMID:38829802
Feasibility of discontinuing immunosuppression in children with idiopathic nephrotic syndrome., PMID:38270600
Rituximab in idiopathic nephrotic syndrome: still waiting for stronger evidences., PMID:37815432
Successful global anti-B-cell strategy with daratumumab in a patient with post-transplant nephrotic syndrome recurrence unresponsive to immunoadsorption and obinutuzumab., PMID:37226549
Rituximab-associated hypogammaglobulinemia in children with idiopathic nephrotic syndrome: results of an ESPN survey., PMID:37014530
A spectrum of novel anti-vascular endothelial cells autoantibodies in idiopathic nephrotic syndrome patients., PMID:36863601
Comparative Study of Serum IgE Level in Frequent Relapse and Infrequent Relapse Nephrotic Syndrome in Children., PMID:36594295
Collagen IV and Podocyte-Related Gene Variants in Patients with Concurrent IgA Nephropathy and Thin Basement Membrane Nephropathy., PMID:36349777
B cell phenotype, activity, and function in idiopathic nephrotic syndrome., PMID:36316536
Tubular epithelial progenitors are excreted in urine during recovery from severe acute kidney injury and are able to expand and differentiate in vitro., PMID:36285332
Rituximab therapy for childhood onset idiopathic nephrotic syndrome: experience of a Portuguese tertiary center., PMID:36259942
Protocol for an open-label, single-arm, multicentre clinical study to evaluate the efficacy and safety of rituximab in the first episode of paediatric idiopathic nephrotic syndrome., PMID:36223961
Changes in Patterns of Infection Associated with Pediatric Idiopathic Nephrotic Syndrome: A Single-Center Experience in Japan., PMID:36223870
A Novel Mouse Model of Idiopathic Nephrotic Syndrome Induced by Immunization with the Podocyte Protein Crb2., PMID:35985815
Relapse rate in children with nephrotic syndrome during the SARS-CoV-2 pandemic., PMID:35976441
Long-term Rituximab Therapy in Adult Patients with Idiopathic Nephrotic Syndrome., PMID:37929543
Long-Term Efficacy and Safety of Repeated Rituximab to Maintain Remission in Idiopathic Childhood Nephrotic Syndrome: An International Study., PMID:35354600
Seven novel podocyte autoantibodies were identified to diagnosis a new disease subgroup-autoimmune Podocytopathies., PMID:34600127
Huangqi Guizhi Wuwu Decoction attenuates Podocyte cytoskeletal protein damage in IgA nephropathy rats by regulating AT1R/Nephrin/c-Abl pathway., PMID:34339916
A critical re-analysis of cases of post-transplantation recurrence in genetic nephrotic syndrome., PMID:34031708
FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury., PMID:32786113
A partial response to abatacept in a patient with steroid resistant focal segmental glomerulosclerosis., PMID:32779421
Idiopathic nephrotic syndrome and serum permeability factors: a molecular jigsaw puzzle., PMID:31848752
Urinary podocyte mRNA is a potent biomarker of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis., PMID:31768862
CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood., PMID:31513327
Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice., PMID:31423748
Plasmonic gold nanoparticles as multifaceted probe for tissue imaging., PMID:30766990
Mutational spectrum and novel candidate genes in Chinese children with sporadic steroid-resistant nephrotic syndrome., PMID:30712057
Global polysome analysis of normal and injured podocytes., PMID:30379099
Auto-immune Thyroiditis in an Infant Masquerading as Congenital Nephrotic Syndrome., PMID:30128632
Mesenchymal stem cells prevent podocyte injury in lupus-prone B6.MRL-Faslpr mice via polarizing macrophage into an anti-inflammatory phenotype., PMID:29982691
Adverse events linked with the use of chimeric and humanized anti-CD20 antibodies in children with idiopathic nephrotic syndrome., PMID:29436729
Confocal super-resolution imaging of the glomerular filtration barrier enabled by tissue expansion., PMID:29241621
Nephrotic syndrome in infants and children: pathophysiology and management., PMID:28914167
Down-regulation of PAX2 promotes in vitro differentiation of podocytes from human CD34+ cells., PMID:28852936
Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α., PMID:28756872
Abdominal distention and continuous feeding intolerance after intraperitoneal kidney transplant: Answers., PMID:28589211
Randomised controlled trial comparing ofatumumab to rituximab in children with steroid-dependent and calcineurin inhibitor-dependent idiopathic nephrotic syndrome: study protocol., PMID:28314744
TdT-positive Infiltrate in Inflamed Pediatric Kidney: A Potential Diagnostic Pitfall., PMID:28248816
The Effect of Cortex/Medulla Proportions on Molecular Diagnoses in Kidney Transplant Biopsies: Rejection and Injury Can Be Assessed in Medulla., PMID:28226404
Construction of a viral T2A-peptide based knock-in mouse model for enhanced Cre recombinase activity and fluorescent labeling of podocytes., PMID:28187984
Valsartan inhibits amylin-induced podocyte damage., PMID:27102209
Partial podocyte replenishment in experimental FSGS derives from nonpodocyte sources., PMID:27076646
Vascular Endothelial Growth Factor and Podocyte Protection in Chronic Hypoxia: Effects of Endothelin-A Receptor Antagonism., PMID:26930122
[Use of rituximab in primary and secondary glomerulonephritis]., PMID:26845209
Anti-CD20 Antibodies for Idiopathic Nephrotic Syndrome in Children., PMID:26585985
B Cell Reconstitution after Rituximab Treatment in Idiopathic Nephrotic Syndrome., PMID:26567244
Cyclophosphamide and rituximab in frequently relapsing/steroid-dependent nephrotic syndrome., PMID:26525199
Low-dose ofatumumab for rituximab-resistant nephrotic syndrome., PMID:26376698
For research use only. Not for human or drug use.
